“…1,[4][5][6] Although intensive insulin therapy is effective in achieving normoglycemia (81-108 mg/dL) in critically ill patients, 7) it often leads to hypoglycemic events and increased mortality in these patients. 8,9) Several recent studies have shown that hyperglycemia and hypoglycemia during surgery, including cardiovascular surgery, are associated with poor outcomes, including the increased risk of adverse events such as surgical site infections (SSI), 1,2,10) postoperative atrial fibrillation (POAF) 11) and coronary artery events, 12) increased duration of hospital stay, 1,13) and increased mortality. 3,5,[14][15][16] Although high blood glucose variability is associated with poor outcomes in critically ill patients, [12][13][14][15] the relationship between blood glucose variability and complications after cardiovascular surgery has not been adequately clarified.…”